This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology.
Sharma, along with Jim Allison, Ph.D., chair of Immunology, leads the immunotherapy platform of MD Anderson’s Moon Shots Program™, a collaborative effort to accelerate the development of scientific discoveries into clinical advances that save patients’ lives.<...
In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting, which...
Patients with stage zero breast cancer, also known as ductal carcinoma in situ, who undergo breast-conserving surgery that results in narrow negative margins may not need additional surgeries if radiation therapy is performed, according to a recent analysis by MD Anderson researchers.
The study, led by Audree Tadros, M.D., and Henry Kuerer, M.D., Ph.D., of the Breast Surgical Oncology department, was conducted to clarify the benefits...
Hurricane Harvey brought with it unprecedented rainfall – 27 trillion gallons – and staggering destruction – 33 Texas counties declared federal...
A number of MD Anderson physicians and scientists chaired or co-chaired sessions and presented research, ranging from racial disparities in...
World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...
In the modern world of biomedical research, collaborations between academic institutions and pharmaceutical and biotech companies have become...
A new trial underway at MD Anderson may lead to new therapies for triple negative breast cancer.
Fifteen to 20% of breast cancers...
Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed to...